Green Cross Holdings Past Earnings Performance
Past criteria checks 1/6
Green Cross Holdings's earnings have been declining at an average annual rate of -57.1%, while the Biotechs industry saw earnings growing at 17.8% annually. Revenues have been growing at an average rate of 7.4% per year.
Key information
-57.1%
Earnings growth rate
-57.1%
EPS growth rate
Biotechs Industry Growth | 11.7% |
Revenue growth rate | 7.4% |
Return on equity | -0.6% |
Net Margin | 1.1% |
Last Earnings Update | 31 Dec 2024 |
Recent past performance updates
Green Cross Holdings' (KRX:005250) Strong Earnings Are Of Good Quality
Mar 25We're Not So Sure You Should Rely on Green Cross Holdings's (KRX:005250) Statutory Earnings
Jan 12Recent updates
Green Cross Holdings' (KRX:005250) Strong Earnings Are Of Good Quality
Mar 25Green Cross Holdings Corporation's (KRX:005250) Price Is Right But Growth Is Lacking
Jan 17Is Green Cross Holdings (KRX:005250) Using Debt Sensibly?
Dec 17Is Green Cross Holdings (KRX:005250) Using Debt Sensibly?
Aug 09Know This Before Buying Green Cross Holdings Corporation (KRX:005250) For Its Dividend
Apr 28Is Now The Time To Put Green Cross Holdings (KRX:005250) On Your Watchlist?
Mar 21Green Cross Holdings (KRX:005250) Seems To Be Using A Lot Of Debt
Mar 01If You Had Bought Green Cross Holdings (KRX:005250) Stock A Year Ago, You Could Pocket A 106% Gain Today
Feb 12Here's What Green Cross Holdings Corporation's (KRX:005250) Shareholder Ownership Structure Looks Like
Jan 28We're Not So Sure You Should Rely on Green Cross Holdings's (KRX:005250) Statutory Earnings
Jan 12Green Cross Holdings Corporation (KRX:005250) Investors Should Think About This Before Buying It For Its Dividend
Dec 28Green Cross Holdings Corporation's (KRX:005250) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Dec 13Green Cross Holdings (KRX:005250) Use Of Debt Could Be Considered Risky
Nov 28Optimistic Investors Push Green Cross Holdings Corporation (KRX:005250) Shares Up 63% But Growth Is Lacking
Nov 28Revenue & Expenses Breakdown
How Green Cross Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 24 | 2,204,855 | 23,777 | 429,577 | 174,644 |
30 Sep 24 | 2,181,325 | -67,892 | 427,836 | 161,802 |
30 Jun 24 | 2,113,064 | -75,257 | 428,949 | 162,912 |
31 Mar 24 | 2,089,633 | -68,156 | 426,954 | 168,083 |
31 Dec 23 | 2,057,936 | -53,311 | 419,632 | 179,470 |
30 Sep 23 | 2,022,765 | -4,483 | 426,536 | 196,019 |
30 Jun 23 | 2,034,738 | 6,689 | 418,054 | 204,932 |
31 Mar 23 | 2,015,489 | 9,763 | 416,239 | 208,850 |
31 Dec 22 | 2,079,560 | 33,457 | 408,479 | 193,945 |
30 Sep 22 | 2,080,210 | 14,585 | 401,716 | 184,627 |
30 Jun 22 | 2,057,372 | 32,002 | 395,429 | 177,894 |
31 Mar 22 | 1,997,197 | 39,712 | 388,835 | 154,316 |
31 Dec 21 | 1,840,559 | 54,901 | 376,468 | 147,282 |
30 Sep 21 | 1,839,742 | 9,620 | 361,495 | 147,785 |
30 Jun 21 | 1,775,100 | 29,238 | 347,233 | 135,340 |
31 Mar 21 | 1,722,665 | 65,565 | 319,163 | 141,602 |
31 Dec 20 | 1,719,326 | 60,806 | 301,464 | 143,311 |
30 Sep 20 | 1,612,253 | 96,771 | 270,036 | 128,912 |
30 Jun 20 | 1,540,220 | 72,006 | 251,017 | 127,916 |
31 Mar 20 | 1,488,624 | 48,269 | 225,374 | 127,162 |
31 Dec 19 | 1,493,589 | 42,741 | 221,067 | 126,347 |
30 Sep 19 | 1,492,852 | 29,228 | 222,126 | 122,954 |
30 Jun 19 | 1,496,677 | 18,310 | 221,204 | 124,867 |
31 Mar 19 | 1,551,002 | -222 | 227,157 | 124,320 |
31 Dec 18 | 1,548,715 | 18,465 | 221,863 | 122,405 |
30 Sep 18 | 1,519,208 | 26,751 | 204,758 | 119,275 |
30 Jun 18 | 1,522,766 | 38,297 | 198,275 | 115,068 |
31 Mar 18 | 1,494,550 | 59,556 | 191,544 | 108,345 |
31 Dec 17 | 1,465,489 | 43,364 | 185,640 | 103,749 |
30 Sep 17 | 1,479,235 | 62,679 | 178,320 | 108,474 |
30 Jun 17 | 1,433,084 | 55,552 | 173,950 | 109,047 |
31 Mar 17 | 1,397,331 | 50,325 | 175,393 | 110,624 |
31 Dec 16 | 1,354,466 | 47,177 | 172,994 | 109,210 |
30 Sep 16 | 1,272,157 | 25,266 | 174,099 | 109,676 |
30 Jun 16 | 1,224,595 | 47,651 | 167,153 | 101,413 |
31 Mar 16 | 1,169,781 | 57,849 | 159,512 | 97,034 |
31 Dec 15 | 1,132,877 | 65,421 | 154,015 | 95,507 |
30 Sep 15 | 1,106,563 | 66,458 | 148,700 | 83,567 |
30 Jun 15 | 1,093,493 | 64,003 | 149,362 | 80,311 |
31 Mar 15 | 1,057,322 | 52,063 | 144,303 | 75,281 |
31 Dec 14 | 1,044,768 | 56,761 | 141,529 | 75,014 |
30 Sep 14 | 1,030,194 | 54,428 | 134,899 | 74,901 |
30 Jun 14 | 1,006,095 | 43,922 | 128,926 | 76,938 |
Quality Earnings: A005250 has a large one-off loss of ₩70.9B impacting its last 12 months of financial results to 31st December, 2024.
Growing Profit Margin: A005250 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A005250's earnings have declined by 57.1% per year over the past 5 years.
Accelerating Growth: A005250 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A005250 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Biotechs industry (33.1%).
Return on Equity
High ROE: A005250's Return on Equity (-0.6%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/05/08 08:50 |
End of Day Share Price | 2025/05/08 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Green Cross Holdings Corporation is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Sang-Hun Lee | iM Securities |
Jae Hyun Kwon | Mirae Asset Securities Co., Ltd. |
Ji-Won Shin | Mirae Asset Securities Co., Ltd. (Pre-Merger) |